CAPS2 Protein Controls Oxytocin Release — Disruption Impairs Social Behavior

The CAPS2 protein is critical for releasing oxytocin from the brain, and mice lacking CAPS2 in oxytocin neurons show impaired social behavior that can be rescued with intranasal oxytocin.

RPEP-05395AnimalModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal
Evidence
Moderate Evidence
Sample
N=not reported (KO and conditional KO mouse groups)
Participants
CAPS2 knockout and conditional knockout mice

What This Study Found

CAPS2 knockout mice had reduced plasma but increased hypothalamic/pituitary oxytocin levels (release failure). OXT neuron-specific CAPS2 deletion impaired social interaction and recognition, which was rescued by intranasal oxytocin administration.

Key Numbers

Reduced plasma OXT; increased hypothalamic/pituitary OXT; impaired social interaction and recognition; intranasal OXT rescue; CAPS2 expressed in hypothalamic OXT neurons

How They Did This

Animal study. CAPS2 knockout and conditional knockout mice (OXT neuron-specific). Plasma and tissue oxytocin levels measured. Social behavior testing. Intranasal oxytocin rescue experiment. CAPS2 localization in hypothalamic OXT neurons and pituitary.

Why This Research Matters

Understanding how oxytocin release is regulated could lead to treatments for social behavior disorders including autism. If the problem is release rather than production, therapies could target the release mechanism or bypass it with exogenous oxytocin.

The Bigger Picture

This study shifts the focus from oxytocin levels to oxytocin release mechanisms. If some people with social behavior difficulties have adequate oxytocin production but impaired release (due to CAPS2 or similar proteins), targeted therapies could unlock their existing oxytocin stores.

What This Study Doesn't Tell Us

Mouse model — social behavior in mice may not fully represent human social interaction. CAPS2 mutations are rare in autism. Intranasal oxytocin delivery to the brain in humans remains debated. Long-term effects of oxytocin rescue not assessed.

Questions This Raises

  • ?Do some people with autism have CAPS2-related oxytocin release deficits?
  • ?Could drugs that enhance CAPS2 function boost natural oxytocin release?
  • ?Does the intranasal oxytocin rescue persist long-term, or does it require continuous administration?

Trust & Context

Key Stat:
Release failure, not production CAPS2-deficient mice had MORE stored oxytocin but LESS circulating oxytocin — the problem was release, not production
Evidence Grade:
Moderate evidence: well-designed genetic study with conditional knockout and rescue experiments, but limited to mouse models of social behavior.
Study Age:
Published 2021. Oxytocin release mechanisms continue to be studied as potential therapeutic targets for social behavior disorders.
Original Title:
CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.
Published In:
The Journal of neuroscience : the official journal of the Society for Neuroscience, 41(20), 4524-4535 (2021)
Database ID:
RPEP-05395

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does CAPS2 have to do with social behavior?

CAPS2 is a protein that helps nerve cells release neuropeptides like oxytocin. Without CAPS2, oxytocin gets made but stays trapped inside cells. Since oxytocin is crucial for social bonding and interaction, disrupted release leads to social behavior problems in mice.

Could this help understand autism?

Possibly. CAPS2 gene alterations have been found in some people with autism. If impaired oxytocin release contributes to social difficulties in autism, therapies targeting the release mechanism — or bypassing it with intranasal oxytocin — could be beneficial.

Read More on RethinkPeptides

Cite This Study

RPEP-05395·https://rethinkpeptides.com/research/RPEP-05395

APA

Fujima, Shuhei; Yamaga, Ryosuke; Minami, Haruka; Mizuno, Shota; Shinoda, Yo; Sadakata, Tetsushi; Abe, Manabu; Sakimura, Kenji; Sano, Yoshitake; Furuichi, Teiichi. (2021). CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 41(20), 4524-4535. https://doi.org/10.1523/JNEUROSCI.3240-20.2021

MLA

Fujima, Shuhei, et al. "CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.." The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. https://doi.org/10.1523/JNEUROSCI.3240-20.2021

RethinkPeptides

RethinkPeptides Research Database. "CAPS2 Deficiency Impairs the Release of the Social Peptide O..." RPEP-05395. Retrieved from https://rethinkpeptides.com/research/fujima-2021-caps2-deficiency-impairs-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.